Canadian Agency for Drugs and Technologies in Health. (2019). Dual antiplatelet therapy following percutaneous coronary intervention: Clinical and economic impact of standard versus extended duration: Recommendations. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health.
Chicago Style CitationCanadian Agency for Drugs and Technologies in Health. Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration: Recommendations. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2019.
MLA CitationCanadian Agency for Drugs and Technologies in Health. Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Clinical and Economic Impact of Standard Versus Extended Duration: Recommendations. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2019.